Cornerstone Advisory’s Vaxart VXRT Stock Holding History

Cornerstone Advisory’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,000	Closed	-$19K	–	780
2021 Q4	$19K	Buy	+3,000	New	+$20.5K	﹤0.01%	537

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cornerstone Advisory's VXRT Position: Q1 2022 in Review

Cornerstone Advisory sold out of Vaxart (VXRT) in Q1 2022, closing a stake of 3,000 shares — an estimated $19K sold.

Cornerstone Advisory first reported a position in VXRT in Q4 2021 and held it in 1 quarter. The position peaked at $19K in Q4 2021. 148 funds tracked by Wall St. Rank hold VXRT as of Q1 2022.

Cornerstone Advisory reported no remaining Vaxart position as of Q1 2022 after selling out during the quarter.
Cornerstone Advisory sold 3,000 Vaxart shares in Q1 2022, an estimated $19K.
Cornerstone Advisory first reported a position in Vaxart in Q4 2021 and held it in 1 quarter.
Cornerstone Advisory's Vaxart position peaked at $19K in Q4 2021.
148 funds tracked by Wall St. Rank held Vaxart as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.